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Thyroid hormones (TH, including the pro-hormone thyroxine (T4)
and its active deiodinated derivative 3,3′,5-triiodo-L-thyronine (T3))
are necessary for proper neurodevelopment. The cellular conse-
quences of congenital hypothyroidism have been extensively studied
in the post-natal rodent cerebellum, which is highly sensitive to
hormone deprivation (Anderson, 2007; Koibuchi and Chin, 2000). In
this brain structure, defects have been observed for virtually all cell
types in several models of hypothyroid rodents (Koibuchi, 2009). The
most visible sign of hypothyroidism is the inhibition of inward
migration of external granular layer (EGL) cells, which eventually die
by apoptosis (Lauder, 1977). Gene expression analysis suggests that
granular cells that achieve inward migration in the internal granular
layer (IGL) are also impaired in their terminal differentiation
(Quignodon et al., 2007a). Radial migration of granular cells follows
the radial processes of the Bergmann glia cells, a distinct class of
astrocytes. Upon hypothyroidism, these radial ﬁbers are disorganized
(Morte et al., 2004) and their maturation in delayed (Manzano et al.,
2007a). The maturation of the other types of astrocytes is alsoretarded and most of them remain conﬁned to the white matter
(Manzano et al., 2007a). Purkinje cells are also highly sensitive to TH
deﬁciency, and display marked reduction in their arborization. Both
early morphological transition (Boukhtouche et al., 2010) and late
elimination of superﬂuous synapses made by climbing ﬁbers (Crepel
et al., 1981) depend on T3. It has been recently observed that the
differentiation of cerebellar GABAergic interneuron precursors which
migrate from the white matter into the cerebellar cortex to
differentiate into Golgi II cells, basket cells and stellate cells, is also
compromised (Manzano et al., 2007a). In the white matter,
oligodendrocytes differentiation is hindered, resulting in delayed
axon myelination (Barradas et al., 2001; Younes-Rapozo et al., 2006).
These multiple alterations ﬁnally result in reduced synaptogenesis in
the molecular layer, a process involving close contacts between the
processes of Purkinje neurons, granular cells, GABAergic interneurons
and Bergmann glia (Nicholson and Altman, 1972; Vincent et al., 1982).
T3 acts directly on gene transcription by binding to the nuclear
thyroid hormone receptors (TR) TRα1, TRβ1,and TRβ2, which are
encoded by the THRA and THRB genes respectively. While unliganded
receptors recruit transcription corepressors, their conformation
changes upon T3 binding allows coactivator recruitment and
corepressor release (Flamant et al., 2007). THRA expression in
cerebellum is ubiquitous, although its expression tends to be higher
in post-mitotic cells (Bradley et al., 1989; Mellstrom et al., 1991;
Wallis et al., 2010). THRB is transcribed mainly in Purkinje cells and to
some extent in differentiated oligodendrocytes (Billon et al., 2001;
Carlson et al., 1996) and astrocytes (Manzano et al., 2007a). Although
alternative non-genomic pathways, which do not rely on TR have
been proposed (Davis et al., 2005), genetic evidences supporting a
neurodevelopmental role of these are missing. Therefore, under-
standing the exact inﬂuence exerted by TRs should bring an access to
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various cell types, which participate in the network of cellular
interaction that governs normal cerebellum development.
The respective function of THRA and THRB in this process remains
however uncertain. Initial knock-out studies failed to clarify the
situation as, in contrast to the dramatic consequences of congenital
hypothyroidism, THRA knock-out mice, THRB knock-out mice and
THRA/THRB double knock-out mice do not display obvious cerebellar
defects. This paradox has been solved, and it is now established that
most consequences of congenital hypothyroidism in the brain are due
to the detrimental activity of unliganded TR receptors. Therefore, as
both transactivation and transrepression are lost after knock-out,
THRA knock-out mice display an intermediate phenotype (Flamant
et al., 2002). As expected from this hypothesis, when THRA knock-out
mice are made hypothyroid, none of the typical signs of congenital
hypothyroidism appear (Morte et al., 2002). Several dominant-
negative mutations have been introduced in the mouse THRA gene,
maintaining its ability to repress transcriptional activity but prevent-
ing gene activation (Kaneshige et al., 2001; Liu et al., 2002; Quignodon
et al., 2007b; Tinnikov et al., 2002) with variable but similar outcomes.
Superﬁcial histological analyses indicate that they display at least the
major features of congenital hypothyroidism (Quignodon et al.,
2007b; Venero et al., 2005). The situation for THRB is puzzling. The
GC-1 selective TRβ1/2 ligand can rescue some of the defects observed
in congenital hypothyroidism, partially restoring Purkinje cell
arborization (Morte et al., 2002) and GABAergic interneuron
differentiation (Manzano et al., 2007b) but having no effect on
Bergmann glia maturation (Morte et al., 2004) or granular cell
precursor radial migration. Two dominant-negative mutations have
been produced (Hashimoto et al., 2001; Kaneshige et al., 2000)
resulting in increased T3 level and, at least for the TRβΔ337T mutation,
in cerebellar defect (Hashimoto et al., 2001). Surprisingly, the cere-
bellum phenotype includes foliation defect, a feature that is not
commonly observed in case of hypothyroidism (Portella et al., 2010).
To address the exact involvement of TRα1 in cerebellar develop-
ment we used the recently generated THRA knock-in allele expressing
the TRα1L400R mutated receptor (Quignodon et al., 2007b). This
mutation speciﬁcally prevents the recruitment of histone acetyl
transferase coactivators without preventing corepressors recruitment
or T3 binding, resulting in a strong dominant-negative activity.
Although mice heterozygous for this mutation have normal T3 and T4
levels, they display many features of congenital hypothyroidism in
tissues and cell types where THRA function is predominant, but not in
retina, inner ear, pituitary TSH cells and liver, where T3 signaling
relies mainly on THRB (Forrest et al., 2002; Winter et al., 2006). The
detailed phenotypic analysis of cerebellar development presented
here demonstrates that these mice display many features of
congenital hypothyroidism, supporting the view that TRα1 isoform
is speciﬁcally required for proper cerebellum development, even in
Purkinje cells where TRβ1 is also present. In-depth investigation also
provides indication that some of the observed defects are not cell
autonomous consequences of TRa1 mutation.
Material and methods
Transgenic mice
TRαAMI/S mice, heterozygous for a knock-in THRA allele encoding
the TRα1L400R dominant-negative receptor were bred and genotyped
as previously described (Quignodon et al., 2007b).
Antibodies for immunocytochemistry
The following antibodies were used: Rabbit anti-Calbindin-D-28k
(Swant, 1:2000 dilution); Rabbit anti-GFAP (Dako 1:2000; for western
blotting and immunoﬂuorescence); Mbp (1:500 for western blottingSanta Cruz); Mouse anti-parvalbumin (1:10,000, Sigma), Rabbit anti-
PAX2 (Zymed diluted 1:500 for western blotting; 1:750 for immuno-
ﬂuorescence); Rabbit anti-PAX6 (1:500, Millipore); mouse anti-
S100β (1:1000, Sigma) and α-tubulin (1:5000 for western blotting,
Santa Cruz). All secondary antibodies were raised in donkey (Jackson
Immunoresearch) and used at a 1:1000 dilution.
Immunoﬂuorescence and confocal imaging
Mice were deeply anesthetized and then transcardially perfused
with 4% PFA in phosphate buffer 0.1 M (pH 7.4). Brains were dissected
and post-ﬁxed for 3 h in 4%PFA. Sagittal sections (50 μm-thick) were
cut using a Vibratome (Integraslice 7550 PSDS, Campden Instru-
ments). Slices were blocked in 10% normal donkey serum, 1% cold
water ﬁsh skin gelatin, 0.2% Triton X-100, prior to primary antibodies
incubation (overnight, 4 °C, in PBS containing 0.2% Triton X-100, 1%
normal donkey serum, 1% cold water ﬁsh skin gelatin and 1% DMSO)
and rinsed before application of the secondary antibody. Sections
were mounted in Prolong® Gold (Invitrogen) and imaged with 63×
oil immersion (NA 1.4) or 40× oil immersion (NA 1.25) objectives
using a confocal microscope (SP5 Leica). Channels were acquired
sequentially to avoid bleed-through between DAPI, DyLight488,
DyLight549 and DyLight633.
Analysis of Purkinje cells size and dendritic arborization
The protocol was modiﬁed from a previously reported procedure
(Tsuda et al., 2005). Brieﬂy, sections were stained with anti-Calbindin
antibody and ﬁve optical sections covering 2 μm along the z-axis were
acquired using a ×63 (1.4 NA) objective. The 5-section series was
projected using the ImageJ z-projection function set for maximum
intensity. Each region of interest (ROI) was delineated using thewidth
of Purkinje cell body as the ROI width, and the distance between the
axon initial segment and the inner EGL (P15) or pial surface (P21) as
the ROI length. To obtain average pictures of multiple Purkinje cells,
all ROI pictures from age- and genotype-matching animals were
assembled into a stack and averaged using the ImageJ z-projection
function set for average intensity. Fluorescence intensity proﬁles for
each ROI were obtained using the ImageJ plot proﬁle routine and
expressed as F/Fmax, checking that the maximum value was located
in the regionwhere Purkinje cell bodywas thewidest. All Purkinje cell
ﬂuorescence proﬁles from and genotype-matching animals where
then averaged.
Western blotting
Aliquots of protein extracts (10 μg) were resolved on 10% SDS-
polyacrylamide gels and transferred to nitrocellulose membranes
using standard protocols. Immunoreactive bands were detected and
quantiﬁed using a Licor Odyssey infrared imaging system. Protein
expression was normalized to that of β-tubulin.
Quantitation of mRNA (Q-RT-PCR)
Whole cerebellum RNA was extracted using the RNAeasy kit
(Qiagen). RNA concentrations were measured with a Nanodrop
spectrophotometer and 1 μg of each RNA sample was reverse
transcribed in murine leukemia virus reverse transcriptase (Promega)
and random DNA hexamer primers. Quantitative PCR was performed
according to standard protocol, using either Qiagen Quantitect
SYBRGreen kit and a Stratagene Mx3000Pro thermocycler or Biorad
iQ SYBRGreen kit and the Biorad CFX96 thermocycler. Hprt (hypo-
xanthine guanine phosphoribosyl transferase), a housekeeping gene,
was used as internal control. For each pair of primers, a standard curve
was established and PCR efﬁciency was controlled to be within usable
Table 2















⁎ Signiﬁcantly changed Pb0.05 (Student test).
⁎⁎ Pb0.01.
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and Schmittgen, 2001).
Results
In mice designated as TRαAMI/S, CRE/loxP recombination takes
place in paternal spermatids. As a result, TRα1L400R dominant-
negative receptor is expressed ubiquitously, from the beginning of
development, but not in maternal tissues. Most mutant mice die
within 3–4 weeks after birth, displaying many features of congenital
hypothyroidism, although T3 and T4 serum levels remain unaffected
(Quignodon et al., 2007b). We performed in-depth histological
analysis of TRαAMI/S cerebellum, using littermates heterozygous for
the undeleted allele as controls, at post-natal days 15 (P15) and 21
(P21). These two stages were chosen because they correspond to
developmental stages where most consequences of congenital
hypothyroidism in mouse cerebellum have been reported.
Oligodendrocytes differentiation and myelin formation
Mbp and Plp1 mRNA, which encode respectively the myelin basic
protein (MBP) and the proteolipid protein (PLP) are found only in
terminally differentiated oligodendrocytes. Quantiﬁcation was per-
formed from whole cerebellum at P15 and revealed a signiﬁcant
decrease in both mRNA levels, which were only partially restored at
P21 (Table 1). This corresponded to a similar decrease in MBP protein
level (Table 2). These observations can result either from a reduction
in MBP and PLP protein content of post-mitotic oligodendrocytes, or
more likely, from a delay in the myelination process similar to the one
reported for hypothyroid mice. However OLIG2 immunostaining
failed to reveal an increased density in oligodendrocyte precursor
cells in the cerebellumwhite matter of TRαAMI/Smice at P15 (data not
shown). Interestingly, the level of the so-called Golli-Mbp mRNA,
which transcription from theMbp locus has recently been reported to
be under direct T3 control (Dong et al., 2009), was not reduced but
augmented in the mutant mice (Table 1).Table 1
Relative gene expression level in TRαAMI/S mice measured by quantitative RT-PCR at
P15 and P21 (% of wild-type littermates).
P15
Gene name TRαAMI/S n=11 Gene name TRαAMI/S n=11
Bdnf 38.7±7.2⁎⁎ MBP 57.0±18.3⁎
Gabra6 50.5±21.7⁎ Mbp golli isoforms 205.3±30.4⁎⁎
GAD65 71.7±10.0⁎ Ngf 111.0±13.1
GFAP 133.4±33.5 Ntf3 61±19.4⁎
Glast (Slc1a3) 75±11.1⁎ PlxnA2 256±41.5⁎⁎
Hr 22.4±13⁎⁎ Pcp2 46.1±14.9⁎⁎
Igf1 105.5±35.4 Plp 60±10⁎⁎
Igf2 131.1±47.5 S100β 46.1±3.6⁎
Igf1r 125.6±14.8 Sema6a 185.3±28.2⁎
Igf2r 97.5±11.9
P21
Gene name TRαAMI/S n=4 Gene name TRαAMI/S n=4
Bdnf 124.7±33.8 MBP 88.1±21.8
Gabra6 147±30.4 Mbp golli isoforms 97.3±11.9
GAD65 122.2±.5⁎ Ngf Low expression
GFAP 153.1±123.8 Ntf3 83.2±20.7
Glast (Slc1a3) 125.4±34.2 PlxnA2 350.4±83.3⁎⁎
Hr 38.8±1.7⁎⁎ Pcp2 101±25.4
Igf1 101.7±24.7 Plp 76.5±39.1
Igf2 214.9±110.6 S100β 50.7±8.2⁎⁎
Igf1r 247.5±22.1⁎⁎ Sema6a 353±39.4⁎⁎
Igf2r 143.6±16.4⁎
⁎ Signiﬁcantly changed Pb0.05 (Student test).
⁎⁎ Pb0.01.Blocking TRα1 signaling impairs Purkinje cells morphological
maturation
Purkinje cells showed a strong reduction in both the size and the
density of dendritic arborization at P15, with little sign of recovery by
P21 (Fig. 1). This correlated with a reduction in protein levels for
Calbindin-28k, a Purkinje cells speciﬁc marker, and of parvalbumin, a
protein present in all GABAergic neurons, including Purkinje cells
(Table 2). Expression of Pcp2, a marker of Purkinje cell differentiation
sensitive to T3 deﬁciency (Sandhofer et al., 1998), was also clearly
reduced at P15 (Table 1). These data conﬁrm that Purkinje cells
differentiation is deeply impaired in mutant cerebellum.
Persistent proliferation and radial migration of granular cell progenitors
During cerebellar post-natal development, granule cell progeni-
tors proliferate at the surface of the cerebellum, in the outermost part
of the EGL. Post-mitotic cells then migrate tangentially in the deeperFig. 1. Impaired development of Purkinje cells dendritic arborization. (a) Dotted line
box shows an example of a region of interest used to determine size and density
of Purkinje cells' dendritic arborization using Calbindin-28k immunostaining (red).
(b) Purkinje cells are reduced in size both during (P15) and at the end (P21) of
cerebellar development. Distance to axon initial segment (AIS) was measured for 4
mutants and 4 control mice for more than 50 cells at each stage *: p≤0.001). The
picture inside bars represents the averaged picture of all Purkinje cells measured for
age- and genotype-matching animals. (c) Averaged ﬂuorescence proﬁles of Purkinje
cells show a reduction in the density and size of dendritic arborization. Scale bar, 10 μm.
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Bergmann glia ﬁbers towards the IGL. The persistence of the EGL at
P21 is described as a typical sign of congenital hypothyroidism and is
thought to reﬂect mainly a defect in radial migration. EGL was thicker
in mutants at P15 (Fig. 2a) and still present at P21 (Fig. 2b). PAX6
immunostaining marked the progenitors still present in the TRaAMI/S
EGL at P21 (Fig. 2b). SEMA6A, a class 6 semaphorin expressed in
tangentially migrating progenitors (Kerjan et al., 2005) showed
greater immunoreactivity in the inner part of the EGL of mutant
mice at P15. This correlated with an increase in Sema6AmRNA, as well
as PlxnA2 mRNA, which encodes Plexin-A2, one of the SEMA6A
receptors, both at P15 and P21 (Table 1).
EdU incorporation (injected 24 h before sacriﬁce) was used to
label S-phase cells and indicated the persistence of proliferation in
mutant EGL cells at P21 (Fig. 2b). Presence of elongated PAX6+ nuclei
in contact with Bergmann glia ﬁlaments showed that radial migration
was still occurring at this late stage. Taken together these data in-Fig. 2. Persistent proliferation and delayed radial migration of granule cell progenitors. (a)
(green) progenitors in the EGL and a stronger SEMA6A (red) immunoreactivity in the inner p
in control animals, whereas numerous proliferating EdU-labeled granule cell progenitors s
migrate radially along Bergman glia GFAP-positive processes. Scale bar, 10 μm.dicate that the commitment of granular neuron progenitors from
tangential to radial migration is delayed or arrested in mutant EGL.
Delayed granular cell maturation
Shortly after leaving the inner EGL, differentiating granular cells
start to express NeuN (Weyer and Schilling, 2003) while PAX6 is
down-regulated. In the control mice, immunostaining showed strong
NeuN and weak PAX6 signal in these cells, whereas in TRaAMI/S
mutant mice, a large fraction of the cells were more immunoreactive
to PAX6 (Fig. 3), suggesting a delay of IGL granular cell differentiation
at P15. We also observed a reduced mRNA level at P15, but not
at P21 (Table 1), for Gabra6 a gene encoding the α6 subunit of the
γ-aminobutyric acid type A (GABAA), which expression gradually
increases as granular cells undergo terminal maturation. Hairless
(Hr) is a well-characterized T3 target gene in granular cells, en-
coding a transcription corepressor (Thompson, 1996). The largeCerebellum sections from P15 animals showing an increased number of PAX6-positive
art of EGL in TRαAMI/Smutants. (b) By P21, granule cell progenitors are virtually absent
till remain in TRαAMI/S animals. Some of these cells (arrowheads) keep the ability to
Fig. 3. Delayed maturation of granule cells after inward migration. Double-immunostaining on cerebellar sections at P15 reveals a delay in the down-regulation of PAX6 and up-
regulation of NeuN expression in TRαAMI/S mutants' IGL. Scale bar, 10 μm.
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impairment of T3 signaling in this cell type. Interestingly, no
signiﬁcant decrease in HrmRNA was observed in TRα0/0 knock-out
mice (Gauthier et al., 2001) at P15, conﬁrming that, at least in this
cell type, TRα1 deletion is less detrimental than the TRα1L400R
point mutation (data not shown).
Abnormal Bergmann glia maturation
This speciﬁc type of astrocyte is assumed to be pivotal for granular
cells inward migration, development of Purkinje cell arborization andFig. 4. Bergmann glia shows abnormal morphology in TRαAMI/Smutants. S100β immunostain
GFAP ﬁlaments appear more numerous and thicker, in the area close to the pial surface (arstellate interneuron synaptogenesis in the molecular layer (Ango
et al., 2008). At P15 and P21, immunostaining for the glial ﬁbrillary
acidic protein (GFAP) revealed an abnormal morphology of the
cellular processes in the molecular layer and the frequent displace-
ment of nuclei in the molecular layer (Fig. 4). In the mutant mice,
S100β protein appeared less abundant, whereas GFAP ﬁlaments were
more numerous. Of note, S100β looked closely associated with GFAP
ﬁlaments while it was more diffuse in control animals, a feature
usually found in immature Bergmann glia. Whole cerebellum analysis,
which encompasses other astrocytic cell types expressing the same
markers, indicated an increase in GFAP protein content at P15 and P21ing reveals a frequent mislocalization of Bergmann glia cell bodies (arrowheads), while
rows). Scale bar, 10 μm.
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encodes a glial high afﬁnity glutamate transporter present only in
astrocytes (Table 1).GABAergic interneurons maturation is delayed
PAX2 is a marker of GABAergic interneuron progenitors, which
they express during their outwardmigration from the white matter to
themolecular layer. PAX2 is lost after differentiation of these cells into
stellate or basket cells, but maintained in Golgi cells. These three types
of inhibitory interneurons all contain parvalbumin. We thus com-
bined PAX2 and parvalbumin immunostaining to address the
localization and differentiation status of GABAergic interneuron
progenitors (Fig. 5). Retarded migration and differentiation in mutant
mice was evidenced at P15 in mutants by an increased density in
PAX2+ cells in all cerebellum layers. In particular a 5-fold increase in
PAX2+ nuclei density and a 5-fold decrease in parvalbumin+ cellular
density were observed in the molecular layer where differentiation
normally takes place (Figs. 5a and c). The apparent impairment in
GABAergic interneuronmigration and differentiationwas still obvious
at P21 (Figs. 5b and c). Western blotting conﬁrmed that parvalbuminFig. 5. Delayed maturation of GABAergic interneurons. In P15 TRαAMI/S mutants (a and c, to
in the upper tier of the molecular layer while parvalbumin-positive mature interneuron
mean±SEM; *: p≤0.001; scale bar, 10 μm). By P21 (b and c, middle and bottom graphs), t
the number of mature interneurons is markedly reduced. (n=7 for controls and n=7 Tcontent was decreased and PAX2 content was increased in mutant
cerebellum at both stages (Table 2).
Synaptogenesis
Basket and stellate interneurons differ by the type of inhibitory
synapses that they establish with Purkinje cells. Basket interneurons
form so-called “pinceau synapses” on Purkinje cells axon initial
segment, while stellate interneurons only contact Purkinje cell
dendrites. Pinceau synapses apparently failed to develop in the
TRαAMI/S mutant, as neither parvalbumin nor glutamic acid decar-
boxylase 65 isoform (GAD65) were detected around the axon initial
segment of Purkinje cells (Fig. 6). Parvalbumin+ positive cells where
still present in the innermost part of the molecular layer, where
basket cells usually reside, indicating that the absence of pinceau
synapses is not due to the absence of this cell type.
In the upper part of the molecular layer, GAD65 immunostaining
revealed a strong and persistent reduction in the density of GABAergic
synapses made by stellate cells, correlating with an overall reduction
in Gad65 mRNA level at P15 (Table 1). As recent studies suggest that
Bergmann glia play the role of a guiding scaffold promoting contacts
between Purkinje cells and stellate interneurons and favoring synapsep and bottom graphs), PAX2-positive GABAergic interneuron progenitors accumulate
s are present at a lower density. (n=9 for controls and n=7 for TRαAMI/S mutants;
hese progenitors are still present in the molecular layer of TRαAMI/Smutants, whereas
RαAMI/S mutants; mean±SEM; *: p≤0.001; scale bar, 10 μm).
Fig. 6. Lack of pinceau synapses on Purkinje cells shows deﬁcient basket cell synaptogenesis. In control animals, combined Calbindin-28k/parvalbumin/GAD65 immunostaining
shows the presence of so-called “pinceau synapses” (asterisk) formed by Basket interneurons (arrowheads) on axonal initial segment of Purkinje neurons. These specialized
synapses are absent in TRαAMI/S mutants, despite the proximity of parvalbumin+ Basket interneurons.
356 T. Fauquier et al. / Developmental Biology 356 (2011) 350–358formation (Ango et al., 2008), we performed 3D analysis of contacts
between GABAergic synapses and Bergmann glia ﬁbers. We observed
that the global decrease in the number of GABAergic synapses was
associatedwith a higher number of these contacts (Fig. 7). This suggestsFig. 7. Impaired stellate interneuron synaptogenesis. At both P15 and P21, GAD65
immunostaining showed a reduction in the density of GABAergic synapses formed by
stellate interneurons on Purkinje cells dendrites (a and b, left graph; mean±SEM;
**: p≤0.01). This decrease was associated with a higher proportion of these synapses
contacting GFAP ﬁlaments (arrowheads) (a and b, right graph;mean±SEM; *: p≤0.05;
**: p≤0.01). Scale bar 5 μm.that decreased synaptic density does not result from an initial defect in
contact formation, guided by Bergmannglia, but results fromaneuronal
inability to establish or maintain functional synapses.
Neurotrophin and growth factor signaling
Cerebellum development is coordinated by a complex network of
cell–cell interactions, mediated by direct contacts and exchanges of
soluble factors between various cell types. T3 deﬁciency has been
shown to alter several signaling pathways, which are important for
proper neurodevelopment (reviewed in (Koibuchi and Chin, 2000)).
We used Q-RT-PCR to perform a broad survey of these T3 sensitive
signaling pathways (Table 1). Neurotrophin-3 (NT3, encoded by the
Ntf3 gene) and brain-derived neurotrophic factor (BDNF) are mainly
secreted by mature granular cells and play a critical role in cerebellar
development, notably for Purkinje cell maturation. Both Bndf and Ntf3
mRNA were reduced in mutants at P15. Ngf (encoding Nerve growth
factor) is transiently affected by T3 deﬁciency (Neveu and Arenas,
1996). However Ngf mRNA level was not signiﬁcantly changed in
mutant. Insulin-like growth factors, IGF1 and IGF2 exert a potent
mitogenic effect on EGL cells. IGF1 is made by Purkinje neurons, and
down-regulated in the case of T3 deﬁciency (Elder et al., 2000; Poguet
et al., 2003). Interestingly, neither Igf1 and igf2 mRNA, nor the Igf1r
and Igf2rmRNA, encoding their receptors, showed signiﬁcant changes
in their transcript contents at P15, whereas increased Igf1r and Igf2r
expressions were observed at P21. Therefore there is at least one trait
present in hypothyroid mice, i.e. reduced Igf1 expression, which is not
found in TRaAMI/Smice, although increased receptor expression at P21
might suggest decreased signaling at a late stage. These major
alterations in neurotrophic factor production might be the cause of
some of the observed defects.
Discussion
In the present study, we investigated the post-natal cerebellum
status of mice expressing in a ubiquitous manner the TRα1L400R
mutation. Our observations conﬁrmed the central function of this
receptor in the coordination of the network of cellular interactions
taking place in the developing cerebellum, and bring new insight in
the underlying cellular events. We found that all the cytological
defects reported for congenital hypothyroidism in rodents can be
observed: inhibition of granular cells inward migration, reduced
357T. Fauquier et al. / Developmental Biology 356 (2011) 350–358dendritic arborization of Purkinje cells, abnormal morphology of
Bergmann glia, delayed differentiation of both GABAergic interneu-
rons, delayed myelin formation and reduced synaptogenesis. This is
likely to be accompanied by a reduction in NT3 and BDNF production.
All these features contribute to the ataxia observed in the TRαAMI/S
mutant mice. As most of these mice die after 3–4 weeks of
development, their health status at P21 might explain a perturbed
behavior and indirectly impact neurodevelopment. However, recov-
ery in expression at P21 for genes encoding differentiation markers
(Gad65, Glast, and Pcp2) or trophic factors (Bdnf) suggest that
cerebellar development is not arrested, but mainly affected by local
TRα1L400R expression.
In contrast to THRA knock-out mice which have a very mild
phenotype (Billon et al., 2002; Manzano et al., 2007a, 2007b; Morte
et al., 2002; Poguet et al., 2003), TRaAMI/S knock-in mice display a
cerebellumwith a hypothyroid-like phenotype, despite a normal level
of circulating T3. This conﬁrms the previous general conclusion that
congenital hypothyroidism is mainly a manifestation of the recruit-
ment of corepressors by unliganded TRα1 (Flamant et al., 2002;Morte
et al., 2002), a conformation mimicked here by the TRα1L400R point
mutation. The best quantitative evidence for strong inhibition of
T3/TRα1 signaling in TRaAMI/S is the 5-fold reduction of Hr mRNA, as
this gene is often used as a reporter for T3 signaling in several neuronal
cell types and not affected by TRα knock-out. Although qualitative
differences have been noticed between phenotypes (Vujovic et al.,
2009), the TRα1L400R expressing mice mainly differ from mice
expressing other THRA knock-in mutations TRα1R384C (Tinnikov et
al., 2002), TRα1P398H (Liu et al., 2003) and TRα1PV (Kaneshige et al.,
2001)) by the severity of its phenotype, the only one leading to a high
rate of lethality at weaning time. This correlates well with the highest
afﬁnity of TRα1L400R for histonedeacetylase corepressors (Darimont et
al., 1998). Speciﬁc histological observations of the developing
cerebellum have been reported only for TRα1R384C (Venero et al.,
2005)making precise comparison difﬁcult, but there is at this point no
reason to doubt that these mutations have similar neurodevelop-
mental consequences.
Whether TRβ1 function is affected by the TRα1L400R mutation
remains uncertain. Based on in vitro experiments, it is usually
assumed that TRα1 and TRβ1 can cross-talk in cell types, like Purkinje
cells, where they are both present, and thus share a common
repertoire of target genes. If this is true, the same genes would be
affected by THRA and THRB dominant-negative mutations. However,
we reported before that TRβ1/2 functions are apparently preserved in
TRaAMI/S mice in most tissues and found example where gene
expression is regulated in an isoform-speciﬁc manner (Quignodon
et al., 2007b). Transcriptome analysis in other systems also suggests
that the respective repertoires of TRα1 and TRβ1 target genes do not
fully overlap (Chan and Privalsky, 2009). This leads us to believe that
TRα1 is ensuring a major and distinct function for T3 signaling during
cerebellum development, without interfering with TRβ1 function. In
this respect, the phenotype of Purkinje cells is of particular interest, as
this cell type has been shown to express THRB at a high level
(Mellstrom et al., 1991) although at a later stage than THRA (Wallis
et al., 2010) Precise measurement indicates that arborization defect
persists at P21 in TRaAMI/Smice when TRβ1 is already expressed. The
number of GABAergic synapses on Purkinje cells is also notably
reduced and, in mice that occasionally survive, have long lasting
consequences on cerebellar functions, revealed by ataxia. Therefore
TRβ1 is unable to compensate for the blockade of TRα1 in Purkinje
cells, supporting the previous conclusion based on in vitro experi-
ments (Heuer andMason, 2003) and the use of a TRβ selective agonist
(Morte et al., 2002). Reciprocally we did not observe any down-
regulation of Igf1 in TRaAMI/S mice, suggesting that only liganded
TRβ1can activate Igf1 expression. However, increased Igf1r expression
at P21 might be an indication for decreased IGF1 signaling in TRaAMI/S
mice as well, that could have a different origin.Recent report indicates that the TRβΔ337T mutation (Portella et al.,
2010) produces an original cerebellum phenotype resulting from a
combination of increased T3 level, due to impaired feedback
regulation of T3 production, and defective response to T3 in cells
that express mainly TRβ isoforms. TRβΔ337T/+ mutant mice present
severe deﬁcits in proliferation of granular precursors, arborization of
Purkinje neurons and organization of Bergmann glia ﬁbers. As THRB is
expressed mainly in Purkinje neurons, it is tempting to speculate that
TRβΔ337T expression affects in a cell autonomous manner Purkinje
neurons, and that granular neurons and Bergmann glia defects are
indirect consequences of primary Purkinje defects. Purkinje cell
maturation seems however to necessitate the concomitant or
successive function of both TRα1and TRβ1. T3 stimulates the
secretion of diffusible factors, made by Purkinje cells, which support
the proliferation, migration and terminal differentiation of granular
cell progenitors present in the EGL, which do not express THRA or
THRB at a high level. By promoting the accumulation of post-mitotic
granular cells, T3 also stimulates in an indirect manner the production
of NT3 and BDNF that are made by this cell type. Therefore, the
dynamic network of cell–cell interactions, which governs normal
cerebellar development, appears to rely on T3 signaling, both directly
and indirectly. The ability to restrict the expression of the TRα1L400R
mutation by CREmediated recombination should permit to clarify the
respective contribution of the direct and indirect intervention of
T3 during cerebellar development and access the genetic program
controlled by the TRα1 transcription factor.References
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